Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6012170 | 1.00 | MEN1 (0.32) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL3179619 | 1.00 | MEN1 (0.32) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL14640259 | 0.88 | MEN1 (0.34) | MEN1KMT2AMAPK1CA12CA14 | |
| SCHEMBL2671553 | 0.88 | MEN1 (0.34) | MEN1KMT2AMAPK1CA12CA14 | |
| SCHEMBL23833792 | 0.88 | MEN1 (0.31) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL30198872 | 0.88 | MEN1 (0.31) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL30198800 | 0.88 | MEN1 (0.31) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL30198986 | 0.88 | MEN1 (0.31) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL30198838 | 0.88 | MEN1 (0.31) | MEN1KMT2AALDH1A1TSHRMAPK1 | |
| SCHEMBL19921767 | 0.87 | MEN1 (0.34) | MEN1KMT2AALDH1A1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3354639-B1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2024-02-21 | — | — | EP | claimed |
| EP-3530648-B1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2023-11-08 | — | — | EP | claimed |
| EP-3530648-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD (JP) | 2019-08-28 | — | — | EP | claimed |
| EP-3354639-B1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2024-02-21 | — | — | EP | disclosed |
| EP-3530648-B1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2023-11-08 | — | — | EP | disclosed |
| US-20210386873-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2021-12-16 | — | — | US | disclosed |
| US-11083804-B2 | Precursor compound of radioactive halogen-labeled organic compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2021-08-10 | — | — | US | disclosed |
| US-10953112-B2 | Precursor compound of radioactive halogen-labeled organic compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2021-03-23 | — | — | US | disclosed |
| EP-2978456-B1 | RADIOLABELLING PROCESS | GE HEALTHCARE LTD (GB) | 2021-03-17 | — | — | EP | disclosed |
| EP-2793954-B1 | 18F-FLUCICLOVINE COMPOSITIONS IN CITRATE BUFFERS | GE HEALTHCARE LTD (GB) | 2020-10-21 | — | — | EP | disclosed |
| US-20200282082-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2020-09-10 | — | — | US | disclosed |
| US-20100028258-A1 | Radioactive Diagnostic Imaging Agent | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20100016626-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2128130-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | Nihon Medi-Physics Co., Ltd. (JP) | 2009-12-02 | — | — | EP | disclosed |
| EP-2106808-A1 | RADIOACTIVE DIAGNOSTIC IMAGING AGENT | Nihon Medi-Physics Co., Ltd. (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-20090198085-A1 | Process for Production of Radioactive Fluorine-Labeled Organic Compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-2080526-A1 | RADIOACTIVE DIAGNOSTIC IMAGING AGENT | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-07-22 | — | — | EP | disclosed |
| EP-2017258-A1 | PROCESS FOR PRODUCTION OF RADIOACTIVE FLUORINE-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-01-21 | — | — | EP | disclosed |
| US-20080281121-A1 | Precursor Compound of Radioactive Halogen-Labeled Organic Compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2008-11-13 | — | — | US | disclosed |
| EP-1978015-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2008-10-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11083804-B2 | Precursor compound of radioactive halogen-labeled organic compound | BCAT2, SLCO2B1, ORC3 | MEN1 3670/4885KMT2A 3576/4885ALDH1A1 2188/4885 |
| US-20210386873-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | BCAT2, SLCO2B1, ORC3 | MEN1 3670/4885KMT2A 3576/4885ALDH1A1 2188/4885 |
| US-20100016626-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | FUS, SLC43A1, PFAS | MEN1 1351/4885KMT2A 3174/4885ALDH1A1 3514/4885 |
| US-20090198085-A1 | Process for Production of Radioactive Fluorine-Labeled Organic Compound | FOSB, AFF1, SLCO4C1 | MEN1 797/4885KMT2A 1919/4885ALDH1A1 1287/4885 |
| US-20080281121-A1 | Precursor Compound of Radioactive Halogen-Labeled Organic Compound | BCAT2, SLCO2B1, ORC3 | MEN1 3670/4885KMT2A 3576/4885ALDH1A1 2188/4885 |
| US-20200282082-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | BCAT2, SLCO2B1, ORC3 | MEN1 3670/4885KMT2A 3576/4885ALDH1A1 2188/4885 |
| US-10953112-B2 | Precursor compound of radioactive halogen-labeled organic compound | BCAT2, SLCO2B1, ORC3 | MEN1 3670/4885KMT2A 3576/4885ALDH1A1 2188/4885 |
| US-20100028258-A1 | Radioactive Diagnostic Imaging Agent | GFPT1, FBP1, PFKFB2 | MEN1 106/4885KMT2A 2475/4885ALDH1A1 2670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.